For media enquiries please contact:

Latest Press Release

Evive Biotech Announces the Appointment of Dr. Liping Sun as Senior VP, Global Head of R&D

U.S. FDA Accepts Biologics License Application for Ryzneuta™

Evive Biotech’s GMP Facility Receives Manufacture License of Pharmaceutical Products

Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™

Evive Biotech and Dr. Xiao Qiang Yan Form Joint Venture to Further Develop Bi-specific Antibody Platform ITab

Evive Biotech Announces First Patient Dosed in Phase 2 Study to Evaluate the Efficacy and Safety of F-652 in Patients with Moderate to Severe COVID-19

Mucosal Immunology Article Details IL-22’s Critical Role in Maturation of Certain Epithelial Cells

Evive Biotech Meets Primary and Secondary Endpoints in Global Phase III Clinical Trial for Their Novel Chemotherapy-induced Neutropenia Treatment

Evive Successfully Concludes China Phase III Clinical Trial of F-627 for Chemotherapy-induced Neutropenia

Media Library